Skip to main content
SpringerLink
Log in

Improve adherence to guideline medications in older patients who have undergone coronary bypass surgery

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Sengstock D, Vaitkevicius P, Salama A, et al. Under-prescribing and non-adherence to medications after coronary bypass surgery in older adults: strategies to improve adherence. Drugs Aging 2012; 29 (2): 93–103

    Article  PubMed  Google Scholar 

  2. Banning M. A review of interventions used to improve adherence to medication in older people. Int J Nurs Stud 2009 Nov; 46 (11): 1505–5

    Article  PubMed  Google Scholar 

  3. Rouleau JL, Warnica WJ, Baillot R, et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 2008 Jan 1; 117 (1): 24–31

    Article  PubMed  CAS  Google Scholar 

  4. Goldman S, Copeland J, Moritz T, et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy: results of a Veterans Administration cooperative study. Circulation 1989 Nov; 80 (5): 1190–7

    Article  PubMed  CAS  Google Scholar 

  5. Crystal E, Connolly SJ, Sleik K, et al. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002 Jul 2; 106 (1): 75–80

    Article  PubMed  Google Scholar 

  6. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 1997 Jan 16; 336 (3): 153–62

    Article  Google Scholar 

  7. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000 Jan 20; 342 (3): 145–53

    Article  PubMed  CAS  Google Scholar 

  8. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003 Sep 6; 362 (9386): 782–8

    Article  PubMed  CAS  Google Scholar 

  9. Braunwald E, Domanski MJ, Fowler SE, et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004 Nov 11; 351 (20): 2058–68

    Article  PubMed  CAS  Google Scholar 

  10. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994 Jan 8; 308 (6921): 81–106

    Article  Google Scholar 

  11. Pedersen TR. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction. N Engl J Med 1985 Oct 24; 313 (17): 1055–8

    Article  PubMed  CAS  Google Scholar 

  12. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002 Nov 23; 360 (9346): 1623–30

    Article  PubMed  CAS  Google Scholar 

  13. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004 Oct 5; 110 (14): e340–437

    PubMed  Google Scholar 

  14. Foody JM, Ferdinand FD, Galusha D, et al. Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction. Circulation 2003 Sep 9; 108 Suppl. 1: II24–8

    PubMed  Google Scholar 

  15. Fonarow GC, Abraham WT, Albert NM, et al. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2007 Jan; 153 (1): 82.e1–11

    Article  Google Scholar 

  16. Kjellgren KI, Ahlner J, Saljo R. Taking antihypertensive medication: controlling or co-operating with patients? Int J Cardiol 1995 Jan 6; 47 (3): 257–68

    Article  PubMed  CAS  Google Scholar 

  17. Steinman MA, Hanlon JT. Managing medications in clinically complex elders: ‘there’s got to be a happy medium’. JAMA 2010 Oct 13; 304 (14): 1592–601

    Article  PubMed  CAS  Google Scholar 

  18. Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med 2007 Sep; 4 (9): e283

    Article  PubMed  Google Scholar 

  19. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006 Dec 6; 296 (21): 2563–71

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Improve adherence to guideline medications in older patients who have undergone coronary bypass surgery. Drugs Ther Perspect 28, 24–26 (2012). https://doi.org/10.1007/BF03262131

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03262131

Keywords

Search

Navigation